Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Azithromycin dihydrate 250mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycindihydrat 1 g suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycindihydrat 250 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycindihydrat 600 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycindihydrat 100 mg/5 ml suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
Azithromycin dihydrate 200mg/ 5 mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycindihydrat 1200 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
Azithromycin dihydrate 200mg/5 mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycindihydrat 100 mg/ml pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycin 250 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycin 1 g/pakke til oral anvendelse (pulver til rekonstitution) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
Product containing precisely azithromycin 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycin 500 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
|
azithromycin 250 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycin 500 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycin 500 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycindihydrat 250 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycindihydrat 250 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycindihydrat 600 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycindihydrat 600 mg tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycindihydrat 250 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycin 250 mg kapsel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycindihydrat 600 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycin 500 mg tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
azithromycin 500 mg pulver til injektionsvæske, opløsning, hætteglas |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin dihydrate 15 milligram/1 gram conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |
Product containing precisely azithromycin dihydrate 15 milligram/1 gram conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Azithromycin dihydrate |
Inferred relationship |
Some |
1 |